検索結果 - Allan Vaag

結果の絞り込み
  1. 1
    THERAPY OF ENDOCRINE DISEASE: Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues

    THERAPY OF ENDOCRINE DISEASE: Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin... 著者: Allan Vaag, Sørens Lund

    出版事項 2011
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?

    Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention? 著者: Allan Vaag, Søren S. Lund

    出版事項 2007
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Genetics of diabetes-associated microvascular complications

    Genetics of diabetes-associated microvascular complications 著者: Valeriya Lyssenko, Allan Vaag

    出版事項 2023
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  4. 4
    Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time

    Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time 著者: Baptist Gallwitz, Allan Vaag, A Falahati, Sten Madsbad

    出版事項 2009
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

    Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. 著者: Allan Vaag, Jan Erik Henriksen, Henning Beck‐Nielsen

    出版事項 1992
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    MECHANISMS IN ENDOCRINOLOGY: SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism?

    MECHANISMS IN ENDOCRINOLOGY: SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism? 著者: Russell Esterline, Allan Vaag, Jan Oscarsson, Jiten Vora

    出版事項 2018
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  7. 7
    Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins

    Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins 著者: Pernille Poulsen, Klaus Levin, Henning Beck‐Nielsen, Allan Vaag

    出版事項 2002
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    The Epigenetic Basis of Twin Discordance in Age-Related Diseases

    The Epigenetic Basis of Twin Discordance in Age-Related Diseases 著者: Pernille Poulsen, Manel Esteller, Allan Vaag, Mario F. Fraga

    出版事項 2007
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  9. 9
    Retinol-Binding Protein 4 in Twins

    Retinol-Binding Protein 4 in Twins 著者: Rasmus Ribel‐Madsen, Martin Friedrichsen, Allan Vaag, Pernille Poulsen

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Reduced glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus

    Reduced glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus 著者: P. Damsbo, Allan Vaag, Ole Hother‐Nielsen, Henning Beck‐Nielsen

    出版事項 1991
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Genetic versus environmental aetiology of the metabolic syndrome among male and female twins

    Genetic versus environmental aetiology of the metabolic syndrome among male and female twins 著者: Pernille Poulsen, Allan Vaag, Kirsten Ohm Kyvik, Henning Beck‐Nielsen

    出版事項 2001
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study

    Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study 著者: Pernille Poulsen, Kirsten Ohm Kyvik, Allan Vaag, Henning Beck‐Nielsen

    出版事項 1999
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    The thrifty phenotype hypothesis revisited

    The thrifty phenotype hypothesis revisited 著者: Allan Vaag, Louise Groth Grunnet, G. P. Arora, Charlotte Brøns

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

    Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? 著者: Kristine Færch, K. Borch‐Johnsen, Jens J. Holst, Allan Vaag

    出版事項 2009
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Expression of insulin regulatable glucose transporters in skeletal muscle from Type 2 (non-insulin-dependent) diabetic patients

    Expression of insulin regulatable glucose transporters in skeletal muscle from Type 2 (non-insulin-dependent) diabetic patients 著者: Aase Handberg, Allan Vaag, P. Damsbo, Henning Beck‐Nielsen, J. Vinten

    出版事項 1990
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Differential effects of casein versus whey on fasting plasma levels of insulin, IGF-1 and IGF-1/IGFBP-3: results from a randomized 7-day supplementation study in prepubertal boys

    Differential effects of casein versus whey on fasting plasma levels of insulin, IGF-1 and IGF-1/IGFBP-3: results from a randomized 7-day supplementation study in prepubertal boys 著者: Camilla Hoppe, Christian Mølgaard, C Dalum, Allan Vaag, Kim F. Michaelsen

    出版事項 2009
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

    Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus 著者: Bianca Hemmingsen, Søren S. Lund, Christian Gluud, Allan Vaag, Thomas Almdal, Jørn Wetterslev

    出版事項 2015
    全文の入手
    Retratação/Retirada
    お気に入りに追加
    保存先:
  18. 18
    Altered Skeletal Muscle Fiber Composition and Size Precede Whole-Body Insulin Resistance in Young Men with Low Birth Weight

    Altered Skeletal Muscle Fiber Composition and Size Precede Whole-Body Insulin Resistance in Young Men with Low Birth Weight 著者: Christine B. Jensen, Heidi Storgaard, Sten Madsbad, Erik A. Richter, Allan Vaag

    出版事項 2007
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study

    Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study 著者: Kristine Færch, K. Borch‐Johnsen, Allan Vaag, Torben Jørgensen, Daniel R. Witte

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs

    Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs 著者: Pernille Poulsen, Allan Vaag, Kirsten Ohm Kyvik, Dorte Møller Jensen, Henning Beck‐Nielsen

    出版事項 1997
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: